The vision of the Centre of Molecular Inflammation Research (CEMIR) is to lay the foundation for identifying new therapeutic targets and developing new diagnostic tools for inflammatory diseases. This will happen through an integrated 10-year programme of research and research training in molecular innate immune responses. Inflammation is a host response that is triggered by infection and tissue injury. A controlled inflammatory response is needed to fight infections and to heal wounds, but it can become detrimental if it is dysregulated as seen in chronic inflammatory disorders like cardiovascular disease, diabetes, Alzheimer's disease, inflammatory bowel disease, obesity, cancer, and others. CEMIR was established at the Faculty of Medicine and Health Sciences, NTNU, in 2013 as a Centre of Excellence (SFF) appointed by the Research Council of Norway.